Nitrocontin 2.6 mg Dosing for Angina
Nitrocontin (controlled-release nitroglycerin) 2.6 mg tablets should be dosed twice daily with an asymmetric schedule (e.g., 8 AM and 2 PM) to provide a mandatory nitrate-free interval of at least 14 hours overnight, preventing tolerance while maintaining daytime anti-anginal coverage. 1
Standard Dosing Regimen
Initial dose: 2.6 mg twice daily, administered in the morning (e.g., 8 AM) and early afternoon (e.g., 2 PM), ensuring the second dose is taken approximately 6-7 hours after the first. 1
The asymmetric dosing schedule is critical—spacing doses 6-7 hours apart rather than 12 hours apart preserves a nitrate-free interval of 14+ hours (typically overnight) to prevent complete tolerance development. 1, 2
Continuous 24-hour nitrate exposure leads to complete tolerance within 24-48 hours, rendering the medication ineffective; therefore, the overnight nitrate-free period is non-negotiable. 1, 3
Titration Guidelines
Upward Titration
Increase to 5.2 mg (two tablets) twice daily if anginal symptoms persist during daytime coverage hours, provided systolic blood pressure remains >100 mmHg and the patient tolerates the medication without significant headache or dizziness. 1
Titrate every 24-48 hours based on symptom control and blood pressure tolerance. 1
Downward Titration
Reduce the dose when systolic blood pressure falls below 100 mmHg or drops >30 mmHg from baseline, or if symptomatic hypotension, severe headache, or dizziness occur. 1
Monitor blood pressure before each dose for the first 48-72 hours, then at least daily during any dose adjustments. 1
Missed Dose Instructions
If a dose is missed during the coverage window (morning or afternoon), take it as soon as remembered—but only if it is still within the intended 12-14 hour daytime coverage period. 1
Do not take a missed dose in the evening or at bedtime, as this would eliminate the mandatory nitrate-free interval and accelerate tolerance development. 1
Never double the next dose to make up for a missed dose, as this increases the risk of hypotension. 1
If both daily doses are missed, resume the regular schedule the following morning; do not attempt to "catch up." 1
Critical Monitoring Parameters
Blood pressure should be checked before each dose initially, especially in elderly or volume-depleted patients who are at higher risk for orthostatic hypotension. 1
Heart rate monitoring is required; avoid dosing when heart rate is <50 bpm or >100 bpm in the absence of symptomatic heart failure. 1
Document anginal episodes and their timing relative to each dose to guide whether titration is needed. 1
Absolute Contraindications
Do not initiate within 24 hours of sildenafil or vardenafil use, or within 48 hours of tadalafil use, due to risk of life-threatening hypotension, myocardial infarction, and death. 4, 1
Systolic blood pressure <90 mmHg or >30 mmHg below baseline is an absolute contraindication. 1
Right ventricular infarction is a contraindication, as nitrates critically reduce preload in these preload-dependent patients. 1
Severe bradycardia (<50 bpm) or tachycardia (>100 bpm) without symptomatic heart failure contraindicates use. 1
Management of Breakthrough Angina During Nitrate-Free Hours
Maintain the nitrate-free interval—do not shift doses to cover nighttime symptoms, as this will cause tolerance and loss of daytime efficacy. 1
Optimize beta-blocker dosing to maximum tolerated dose to control residual angina during patch-off hours. 1
Add or uptitrate a calcium-channel blocker (non-dihydropyridine if beta-blocker is contraindicated, or dihydropyridine with adequate beta-blockade). 1
Provide sublingual nitroglycerin 0.3-0.4 mg for acute breakthrough symptoms during the nitrate-free interval. 4, 1
Consider earlier invasive revascularization if optimized medical therapy fails to control symptoms. 1
Common Pitfalls to Avoid
Symmetric twice-daily dosing (e.g., 8 AM and 8 PM) will cause complete tolerance—always use asymmetric scheduling with a 14+ hour nitrate-free interval. 1, 2
Headache is common initially but usually resolves within days; it does not require discontinuation unless severe. 5
Rebound ischemia during the nitrate-free interval occurs in some patients (increased angina frequency during patch-off hours), but this is managed by optimizing other anti-anginal agents, not by eliminating the nitrate-free period. 6
Do not delay or replace proven mortality-reducing therapies (beta-blockers, ACE inhibitors, high-intensity statins) with nitrate therapy—nitrates provide symptom relief only and do not reduce mortality. 1